Whatever happened to cassette-dosing pharmacokinetics?

Drug Discovery Today

Volumn 9, Issue 15, 2004, Pages 652-658

  Manitpisitkul, Prasarn ^a   White, Ronald E ^b  

^a JOHNSON AND JOHNSON   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

cassette; Drug Discovery; drug discovery; Pharmaceutical Science; pharmacokinetics; screening; Techniques Methods

Indexed keywords

MACROGOL; METHYLCELLULOSE;

AREA UNDER THE CURVE; BLOOD SAMPLING; CASSETTE DOSING; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG INDUSTRY; DRUG METABOLISM; DRUG SCREENING; DRUG SOLUBILITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METHODOLOGY; REVIEW;

ANIMALS; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; DRUG INDUSTRY; PHARMACOKINETICS;

EID: 3242778456     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(04)03137-X     Document Type: Review

References (28)

1. Kerns E.H., Di L. Pharmaceutical profiling in drug discovery. Drug Discov. Today. 8:2003;316-323
2. White R.E. A comprehensive strategy for ADME screening in drug discovery. Borchardt R.T.,, et al. Pharmaceutical Profiling in Drug Discovery for Lead Selection. 2004;431-450 American Association of Pharmaceutical Scientists Press
3. Di L., Kerns E.H. Profiling drug-like properties in discovery research. Curr. Opin. Chem. Biol. 7:2003;402-408
4. Roberts S.A. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics. Xenobiotica. 31:2001;557-589
5. Berman J., et al. Simultaneous pharmacokinetic screening of a mixture of compounds in the dog using API LC/MS/MS analysis for increased throughput. J. Med. Chem. 40:1997;827-829
6. Ackermann B.L., et al. Recent advances in use of LC/MS/MS for quantitative high-throughput bioanalytical support of drug discovery. Curr. Top. Med. Chem. 2:2002;53-66
7. Bayliss M.K., Frick L.W. High-throughput pharmacokinetics: cassette dosing. Curr. Opin. Drug Disc. Dev. 2:1999;20-25
8. White R.E., Manitpisitkul P. Pharmacokinetic theory of cassette dosing in drug discovery screening. Drug Metab. Dispos. 29:2001;957-966
9. Christ D.D. Cassette dosing pharmacokinetics: valuable tool or flawed science? Drug Metab. Dispos. 29:2001;935
10. Hasegawa K., et al. Cassette dosing approach and quantitative structure-pharmacokinetic relationship study of antifungal N- myristoyltransferase inhibitors. J. Chem. Inf. Comput. Sci. 42:2002;968-975
11. Mallis L.M., et al. Determination of rat oral bioavailability of soy-derived phytoestrogens using an automated on-column extraction procedure and electrospray tandem mass spectrometry. J. Chromatog. B. Analyt. Technol. Biomed. Life Sci. 796:2003;71-86
12. Tamvakopoulos C.S., et al. Determination of brain and plasma drug concentrations by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 14:2000;1729-1735
13. Zhang M-Y, et al. Brain and plasma exposure profiling in early drug discovery using cassette administration and fast liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 34:2004;359-368
14. Choo E.F., et al. Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. Drug Metab. Dispos. 28:2000;655-660
15. Macdonald S.J.F., et al. Discovery of further pyrrolidine trans-lactams and inhibitors of human neutrophil elastase (HNE) with potential as development candidates and the crystal structure of HNE complexed with an inhibitor (GW475151). J. Med. Chem. 45:2002;3878-3890
16. Andrews D.M., et al. Pyrrolidine-5,5-trans-lactams. 5. pharmacokinetic optimization of inhibitors of hepatitis C virus NS3/4A protease. Org. Lett. 5:2003;4631-4634
17. Ward K.W., et al. Development of an in vivo preclinical screen model to estimate absorption and bioavailability of xenobiotics. Drug Metab. Dispos. 29:2001;82-88
18. Ibrahim A.E., et al. Simultaneous assessment of drug interactions with low- and high-extraction opioids. Anesthesiology. 98:2003;853-861
19. Zhou H., et al. 'Cocktail' approaches and strategies in drug development: valuable tool or flawed science? J. Clin. Pharmacol. 44:2004;120-134
20. Rajanikanth M., Gupta R.C. LC fluorescence method for multiple synthetic compounds to rapidly create in vivo pharmacokinetic database utilizing 'N-in-one' dosing. J. Pharm. Biomed. Anal. 26:2001;519-530
21. Keseru G.M., Molnar L. METAPRINT: a metabolic fingerprint. Application to cassette design for high-throughput ADME screening. J. Chem. Inf. Comput. Sci. 42:2002;437-444
22. Ohkawa T., et al. A new generic column switching system for quantitation in cassette dosing using LC/MS/MS. J. Pharm. Biomed. Anal. 31:2003;1089-1099
23. Cox K.A., et al. Rapid determination of pharmacokinetic properties of new chemical entities: in vivo approaches. Comb. Chem. High Throughput Screen. 5:2002;29-37
24. Timmerman P.M.M.B.L., et al. Tailoring bioanalysis for PK studies supporting drug discovery. Curr. Top. Med. Chem. 1:2001;443-461
25. Atherton J.P., et al. Sample pooling to enhance throughput of brain penetration study. J. Pharm. Biomed. Anal. 20:1999;39-47
26. Cai Z., et al. High-throughput analysis in drug discovery: application of liquid chromatography/ion-trap mass spectrometry for simultaneous cassette analysis of α-1a antagonists and their metabolites in mouse plasma. Rapid Commun. Mass Spectrom. 15:2001;546-550
27. Hsieh Y., et al. Direct cocktail analysis of drug discovery compounds in pooled plasma samples using liquid chromatography-tandem mass spectrometry. J. Chromatog. B. Analyt. Technol. Biomed. Life Sci. 767:2002;353-362
28. Korfmacher W.A., et al. Cassette-accelerated rapid rat screen: a systematic procedure for the dosing and liquid chromatography/atmospheric pressure ionization tandem mass spectrometric analysis of new chemical entities as part of new drug discovery. Rapid Commun. Mass Spectrom. 15:2001;335-340